Cardinal Health, Inc.
CAH · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $64,009,000 | $60,159,000 | $54,878,000 | $55,264,000 |
| % Growth | 6.4% | 9.6% | -0.7% | – |
| Cost of Goods Sold | $61,690,000 | $57,957,000 | $52,755,000 | $53,323,000 |
| Gross Profit | $2,319,000 | $2,202,000 | $2,123,000 | $1,941,000 |
| % Margin | 3.6% | 3.7% | 3.9% | 3.5% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1,461,000 | $1,484,000 | $1,315,000 | $1,306,000 |
| Sales & Mktg Exp. | $1,461,000 | $1,484,000 | $1,315,000 | $1,306,000 |
| Other Operating Expenses | $190,000 | $290,000 | $78,000 | $86,000 |
| Operating Expenses | $1,651,000 | $1,774,000 | $1,393,000 | $1,392,000 |
| Operating Income | $668,000 | $428,000 | $730,000 | $549,000 |
| % Margin | 1% | 0.7% | 1.3% | 1% |
| Other Income/Exp. Net | -$70,000 | -$44,000 | -$65,000 | -$38,000 |
| Pre-Tax Income | $598,000 | $384,000 | $665,000 | $511,000 |
| Tax Expense | $144,000 | $141,000 | $157,000 | $110,000 |
| Net Income | $450,000 | $239,000 | $506,000 | $400,000 |
| % Margin | 0.7% | 0.4% | 0.9% | 0.7% |
| EPS | 1.89 | 1 | 2.11 | 1.65 |
| % Growth | 89% | -52.6% | 27.9% | – |
| EPS Diluted | 1.88 | 1 | 2.1 | 1.65 |
| Weighted Avg Shares Out | 238,000 | 239,000 | 240,000 | 242,000 |
| Weighted Avg Shares Out Dil | 239,000 | 240,000 | 241,000 | 243,000 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $80,000 | $74,000 | $74,000 | $35,000 |
| Depreciation & Amortization | $233,000 | $209,000 | $207,000 | $192,000 |
| EBITDA | $911,000 | $667,000 | $946,000 | $738,000 |
| % Margin | 1.4% | 1.1% | 1.7% | 1.3% |